Get started
Author

Michael Colwill

JAK inhibitors for inflammatory bowel disease: recent advances
2023 · Sailish Honap, Alexandra Agorogianni, et al. · Frontline Gastroenterology · 143
Biomarkers in inflammatory bowel disease: a practical guide
2024 · Jennie Clough, Michael Colwill, et al. · Therapeutic Advances in Gastroenterology · 110
PDF
Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential
2025 · Michael Colwill, Sebastian Povlsen, et al. · Journal of Crohn s and Colitis · 36
Cardiopulmonary resuscitation on television: are we miseducating the public?
2017 · Michael Colwill, Charlotte Somerville, et al. · Postgraduate Medical Journal · 30
Comparative Effectiveness of Tofacitinib vs Upadacitinib for the Treatment of Acute Severe Ulcerative Colitis
2025 · Sailish Honap, Joelle St-Pierre, et al. · Clinical Gastroenterology and Hepatology · 20
PDF
Towards NHS Zero: greener gastroenterology and the impact of virtual clinics on carbon emissions and patient outcomes. A multisite, observational, cross-sectional study.
2022 · Jonathan King, Stephanie X Poo, et al. · Frontline Gastroenterology · 17
PDF
Sphingosine-1-Phosphate (S1P) Receptor Modulators for the Treatment of Inflammatory Bowel Disease (IBD): Mechanisms, Clinical Evidence, and Practical Insights
2025 · Natalie Shields, Michael Colwill, et al. · Biomedicines · 13
PDF
Role of Mirikizumab in the Treatment of Inflammatory Bowel Disease—From Bench to Bedside
2025 · Michael Colwill, Samantha Baillie, et al. · Journal of Clinical Medicine · 12
PDF
Biobanks and biomarkers: Their current and future role in biomedical research
2024 · Michael Colwill, Samantha Baillie, et al. · World Journal of Methodology · 8
PDF
Gastrointestinal tuberculosis: Diagnostic approaches for this uncommon pathology
2024 · Lottie Brown, Michael Colwill, et al. · World Journal of Clinical Cases · 7
Landscape of anti-IL-23 therapy in inflammatory bowel disease: recent advances
2025 · Michael Colwill, Jennifer Clough, et al. · Frontline Gastroenterology · 6
Impact of gender identity in the inflammatory bowel disease population: an evidence review and practical steps for gastroenterologists
2024 · Michael Colwill, Richard Pollok, et al. · Frontline Gastroenterology · 6
Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel Disease
2025 · Michael Colwill, Sailish Honap, et al. · Clinical and Experimental Gastroenterology · 5
PDF
Using national census data to facilitate healthcare research
2023 · Michael Colwill, Andrew Poullis · World Journal of Methodology · 5
Digital twins in IBD—bridging data, biology and trial innovation
2026 · Michael Colwill, Sailish Honap, et al. · Gut · 4
P0832 Real-world effectiveness of risankizumab in Crohn’s Disease: The UK Experience
2025 · A Elford, N Plevris, et al. · Journal of Crohn s and Colitis · 4
Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial
2026 · Nurulamin M Noor, Mohmmed Tauseef Sharip, et al. · The Lancet. Gastroenterology & hepatology · 3
Research surveys and their evolution: Past, current and future uses in healthcare
2024 · Michael Colwill, Richard Pollok, et al. · World Journal of Methodology · 3
Real-world effectiveness of risankizumab in Crohn’s disease: a pan UK retrospective cohort study
2026 · Alexander Thomas Elford, Nathan Constantine-Cooke, et al. · Frontline Gastroenterology · 2
PDF
Patient experiences of gender identity and inflammatory bowel disease: a focus group study
2025 · Michael Colwill, Kevin Jacob, et al. · Frontline Gastroenterology · 2
Transgender and gender diverse populations: lessons from IBD care
2026 · Michael Colwill, Richard Pollok, et al. · The Lancet. Gastroenterology & hepatology · 1
Nomenclature of therapies in inflammatory bowel disease: A journey through time and terminology
2026 · Michael Colwill, Kamal Patel, et al. · Inflammatory Bowel Diseases · 1
P1220 Gender Identity and Inflammatory Bowel Disease: A National Bioresource Study Reveals Delayed Diagnosis, Greater Comorbidity and Poorer Quality of Life
2026 · M Colwill, R Pollok, et al. · Journal of Crohn s and Colitis · 1
PDF
DOP108 Randomised controlled trial of withdrawal of thiopurines in patients with IBD switching from intravenous to subcutaneous infliximab: Results of the MINIMISE study
2026 · P M Irving, A Centritto, et al. · Journal of Crohn s and Colitis · 1
PDF
The impact of ethnicity on delays in initiating advanced therapy for inflammatory bowel disease
2025 · Michael Colwill, Samantha Baillie, et al. · European Journal of Gastroenterology & Hepatology · 1
Works count: 54
Citation count: 448
H-index: 8
I10-index: 8
Year
Topic
Type